The role of epicardial adipose tissue in the development of atrial fibrillation: a literature review

Background. Atrial fibrillation, the most common persistent cardiac arrhythmia, is a common cause of strokes, heart failure, dementia, worsens the quality of life, increases mortality and has a significant impact on the health economy. The obesity pandemic leads to a serious increase in cardiovascular risks. Obesity is closely associated with the development of atrial fibrillation, as it is associated with diseases and conditions leading to structural and functional remodeling of the heart, as well as hypertrophy and dysfunction of epicardial adipose tissue. Epicardial fat is unique in its anatomy, extremely high secretory and metabolic activity, unobstructed proximity to the myocardium and the ability to interact with it due to the general blood flow. Under physiological conditions, epicardial adipose tissue performs a cardioprotective function. Obesity causes hypertrophy and hypoxia of adipocytes. Under these conditions, adipocytes lose their protective properties, epicardial fat mainly produces proinflammatory and profibrotic adipokines, infiltrates the myocardium, which contributes to the development of atrial fibrillation. Studies show that the thickness and volume of epicardial adipose tissue are directly correlated with the risk of atrial fibrillation, the severity of its course, and the recurrence of paroxysms after catheter ablation. Many potential mechanisms of arrhythmia induction in obesity have been discovered. Research is needed to further clarify these mechanisms and identify ways to prevent them. Taking into account the peculiarities of the structure and functions of epicardial adipose tissue, it is of interest as a promising therapeutic target.

Conclusion. This article represents an overview of the most significant scientific works devoted to the problem of epicardial obesity and its relationship with atrial fibrillation, systematizes modern ideas about the potential proarrhythmogenic effect of epicardial adipose tissue, therapeutic possibilities and future prospects.

1. World Obesity. World Obesity Atlas 2023.

2. Rosstat. Federal State Statistics Service. Voluntary national review of the implementation of the 2030 Agenda for Sustainable Development. (In Russ.) Url: https://rosstat.gov.ru/folder/94692 (accessed on 22.02.2024).

3. Liu F., Song T., Hu Q., Zhu X., et al. Body mass index and atrial fibrillation recurrence post ablation: A systematic review and dose-response meta-analysis. Front Cardiovasc Med. 2023; 9: 999845. https://doi.org/10.3389/fcvm.2022.999845.

4. Wong C. X. et al. Obesity and the risk of incident, post-operative, and post-ablation atrial fibrillation: a meta-analysis of 626,603 individuals in 51 studies. JACC: clinical electrophysiology. 2015.

5. Shu H., Cheng J., Li N., et al. Obesity and atrial fibrillation: a narrative review from arrhythmogenic mechanisms to clinical significance. Cardiovasc Diabetol. 2023; 22, 192. https://doi.org/10.1186/s12933-023-01913-5.

6. Packer M. Characterization, Pathogenesis, and Clinical Implications of Inflammation-Related Atrial Myopathy as an Important Cause of Atrial Fibrillation. J Am Heart Assoc. 2020; 9 (7): e015343. https://doi.org/10.1161/JAHA.119.015343.

7. World Health Organization. Obesity and overweight. 2021.

8. Brel N. K., Kokov A. N., Gruzdeva O. V. Advantages and disadvantages of different methods for diagnosis of visceral obesity. Ozhirenie i metabolizm. 2018; 15 (4): 3-8. (In Russ.) https://doi.org/10.14341/omet9510.

9. Krishnan A., Sharma H., Yuan D., et al. The Role of Epicardial Adipose Tissue in the Development of Atrial Fibrillation, Coronary Artery Disease and Chronic Heart Failure in the Context of Obesity and Type 2 Diabetes Mellitus: A Narrative Review. J Cardiovasc Dev Dis. 2022; 9 (7):217. https://doi.org/10.3390/jcdd9070217.

10. Gawałko M., Saljic A., Li N., et al. Adiposity-associated atrial fibrillation: molecular determinants, mechanisms and clinical significance. Cardiovasc Res. 2022 Jun 11: cvac093. https://doi.org/10.1093/cvr/cvac093.

11. Tarsitano M. G., Pandozzi C., Muscogiuri G., et al. Epicardial Adipose Tissue: A Novel Potential Imaging Marker of Comorbidities Caused by Chronic Inflammation. Nutrients. 2022; 14 (14): 2926. https://doi.org/10.3390/nu14142926.

12. Iacobellis G. Epicardial adipose tissue in contemporary cardiology. Nat Rev Cardiol. 2022: 1-14. https://doi.org/10.1038/s41569-022-00679-9.

13. Antonopoulos A. S., Sanna F., Sabharwal N., et al. Detecting human coronary inflammation by imaging perivascular fat. Sci Transl Med. 2017; 9 (398): eaal2658. https://doi.org/10.1126/scitranslmed.aal2658.

14. Gaibazzi N., Martini C., Benatti G., et al. Atrial Fibrillation and Peri-Atrial Inflammation Measured through Adipose Tissue Attenuation on Cardiac Computed Tomography. Diagnostics (Basel). 2021; 11 (11): 2087. https://doi.org/10.3390/diagnostics11112087.

15. Bertaso A. G., Bertol D., Duncan B. B., et al. Epicardial fat: definition, measurements and systematic review of main outcomes. Arq Bras Cardiol. 2013; 101 (1): e18-28. https://doi.org/10.5935/abc.20130138.

16. Kuznetsova T. Yu., Chumakova G. A., Druzhilov M. A., Veselovskaya N. G. Clinical application of quantitative echocardiographic assessment of epicardial fat tissue in obesity. Rossiiskii kardiologicheskii zhurnal. 2017; (4): 81-87. (In Russ.) https://doi.org/10.15829/1560-4071-2017-4-81-87.

17. Thanassoulis G., Massaro J. M., Hoffmann U., et al. Prevalence, distribution, and risk factor correlates of high pericardial and intrathoracic fat depots in the Framingham heart study. Circ Cardiovasc Imaging. 2010; 3 (5): 559-566. https://doi.org/10.1161/CIRCIMAGING.110.956706.

18. Al Chekakie M. O., Akar J. G. Epicardial Fat and Atrial Fibrillation: A Review. J Atr Fibrillation. 2012; 4 (6): 483. https://doi.org/10.4022/jafib.483.

19. Tsao H. M., Hu W. C., Wu M. H., et al. Quantitative analysis of quantity and distribution of epicardial adipose tissue surrounding the left atrium in patients with atrial fibrillation and effect of recurrence after ablation. Am J Cardiol. 2011; 107 (10): 1498-1503. https://doi.org/10.1016/j.amjcard.2011.01.027.

20. Batal O., Schoenhagen P., Shao M., et al. Left atrial epicardial adiposity and atrial fibrillation. Circ Arrhythm Electrophysiol. 2010; 3 (3): 230-236. https://doi.org/10.1161/CIRCEP.110.957241.

21. Wong C. X., Sun M. T., Odutayo A., et al. Associations of Epicardial, Abdominal, and Overall Adiposity With Atrial Fibrillation. Circ Arrhythm Electrophysiol. 2016; 9 (12): e004378. https://doi.org/10.1161/CIRCEP.116.004378.

22. Wong C. X., Mahajan R., Pathak R., et al. The Role of Pericardial and Epicardial Fat in Atrial Fibrillation Pathophysiology and Ablation Outcomes. J Atr Fibrillation. 2013; 5 (5): 790. https://doi.org/10.4022/jafib.790.

23. Kim D., Yu H. T., Kwon O. S., et al. Effect of epicardial fat volume on outcomes after left atrial posterior wall isolation in addition to pulmonary vein isolation in patients with persistent atrial fibrillation. Front Cardiovasc Med. 2022; 9: 1005760. https://doi.org/10.3389/fcvm.2022.1005760.

24. Chahine Y., Askari-Atapour B., Kwan K. T., et al. Epicardial adipose tissue is associated with left atrial volume and fibrosis in patients with atrial fibrillation. Front Cardiovasc Med. 2022; 9: 1045730. https://doi.org/10.3389/fcvm.2022.1045730.

25. Mazurek T., Kiliszek M., Kobylecka M., et al. Relation of proinflammatory activity of epicardial adipose tissue to the occurrence of atrial fibrillation. Am J Cardiol. 2014; 113 (9): 1505-1508. https://doi.org/10.1016/j.amj-card.2014.02.005.

26. Haemers P., Hamdi H., Guedj K., et al. Atrial fibrillation is associated with the fibrotic remodelling of adipose tissue in the subepicardium of human and sheep atria. Eur Heart J. 2017; 38 (1): 53-61. https://doi.org/10.1093/eurheartj/ehv625.

27. Mahajan R., Lau D. H., Brooks A. G., et al. Electrophysiological, Electro-anatomical, and Structural Remodeling of the Atria as Consequences of Sustained Obesity. J Am Coll Cardiol. 2015; 66 (1): 1-11. https://doi.org/10.1016/j.jacc.2015.04.058.

28. Chumakova G., Gritsenko O., Gruzdeva O., Dyleva Y. Analysis of probable lipotoxic damage and myocardial fibrosis in epicardial obesity. Aging (Albany NY). 2021; 13 (11):14806-14815. https://doi.org/10.18632/aging.203148.

29. Wang Q., Min J., Jia L., et al. Human Epicardial Adipose Tissue Activin A Expression Predicts Occurrence of Postoperative Atrial Fibrillation in Patients Receiving Cardiac Surgery. Heart Lung Circ. 2019; 28 (11): 1697-1705. https://doi.org/10.1016/j.hlc.2018.08.010.

30. Venteclef N., Guglielmi V., Balse E., et al. Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines. Eur Heart J. 2015; 36 (13): 795-805a. https://doi.org/10.1093/eurheartj/eht099.

31. Antonopoulos A. S., Antoniades C. The role of epicardial adipose tissue in cardiac biology: classic concepts and emerging roles. J Physiol. 2017; 595 (12): 3907-3917. https://doi.org/10.1113/JP273049.

32. Conte M., Petraglia L., Poggio P., et al. Inflammation and Cardiovascular Diseases in the Elderly: The Role of Epicardial Adipose Tissue. Front Med (Lausanne). 2022; 9: 844266. https://doi.org/10.3389/fmed.2022.844266.

33. Bernasochi G. B., Boon W. C., Curl C. L., et al. Pericardial adipose and aromatase: A new translational target for aging, obesity and arrhythmo-genesis? J Mol Cell Cardiol. 2017; 111: 96-101. https://doi.org/10.1016/j.yjmcc.2017.08.006.

34. Suffee N., Moore-Morris T., Farahmand P., et al. Atrial natriuretic peptide regulates adipose tissue accumulation in adult atria. Proc Natl Acad Sci USA. 2017; 114 (5): E771-E780. https://doi.org/10.1073/pnas.1610968114.

35. Christensen R. H., Wedell-Neergaard A. S., Lehrskov L. L., et al. Effect of Aerobic and Resistance Exercise on Cardiac Adipose Tissues: Secondary Analyses From a Randomized Clinical Trial. JAMA Cardiol. 2019; 4 (8): 778-787. https://doi.org/10.1001/jamacardio.2019.2074.

36. Colonetti T., Grande A. J., Amaral M. C., et al. Effect of exercise on epicardial adipose tissue in adults: a systematic review and meta-analyses. Heart Fail Rev. 2021; 26 (6): 1399-1411. https://doi.org/10.1007/s10741-020-09965-5.

37. Saco-Ledo G., Valenzuela P. L., Castillo-García A., et al. Physical exercise and epicardial adipose tissue: A systematic review and meta-analysis of randomized controlled trials. Obes Rev. 2021; 22 (1): e13103. https://doi.org/10.1111/obr.13103.

38. Khoo J., Dhamodaran S., Chen D. D., et al. Exercise-Induced Weight Loss is More Effective than Dieting for Improving Adipokine Profile, Insulin Resistance, and Inflammation in Obese Men. Int J Sport Nutr Exerc Metab. 2015; 25 (6): 566-575. https://doi.org/10.1123/ijsnem.2015-0025.

39. Mahajan R., Lau D. H., Brooks A. G., et al. Atrial Fibrillation and Obesity: Reverse Remodeling of Atrial Substrate With Weight Reduction. JACC Clin Electrophysiol. 2021; 7 (5): 630-641. https://doi.org/10.1016/j.jacep.2020.11.015.

40. Raggi P., Gadiyaram V., Zhang C., et al. Statins Reduce Epicardial Adipose Tissue Attenuation Independent of Lipid Lowering: A Potential Pleiotropic Effect. J Am Heart Assoc. 2019; 8 (12): e013104. https://doi.org/10.1161/JAHA.119.013104.

41. Rivas Galvez R. E., Morales Portano J. D., Trujillo Cortes R., et al. Reduction of epicardial adipose tissue thickness with PCSK9 inhibitors. Eur. Heart J. 2020; 41((Suppl. 2)): ehaa946-3008. https://doi.org/10.1093/ehjci/ehaa946.3008.

42. Ziyrek M., Kahraman S., Ozdemir E., et al. Metformin monotherapy significantly decreases epicardial adipose tissue thickness in newly diagnosed type 2 diabetes patients. Rev Port. Cardiol. 2019; 38: 419-423. https://doi.org/10.1016/j.repc.2018.08.010.

43. Bratilova E. S., Kachnov V. A., Tyrenko V. V., et al. Fat depot of the heart: contribution to the development of cardiovascular diseases, visualization methods and the possibilities of it’s correction. Vestnik Rossiiskoi Voenno-medicinski akademii. 2020; 3 (71): 211-216. (In Russ.)

44. Dozio E. Epicardial adipose tissue GLP-1 receptor is associated with genes involved in fatty acid oxidation and white-to-brown fat differentiation: a target to modulate cardiovascular risk? Int. J. Cardiol. 2019; 292: 218-224. https://doi.org/10.1016/j.ijcard.2019.04.039.

45. Zheng H., Peng Y., Wang P., Su P., Zhao L. The integrative network of circRNA, miRNA and mRNA of epicardial adipose tissue in patients with atrial fibrillation. Am J Transl Res. 2022; 14 (9): 6550-6562.

46. Mustafina I. A., Ionin V. A., Dolganov A. A., et al. Role of epicardial adipose tissue in the development of cardiovascular diseases. Rossiski kardiologicheskiш zhurnal. 2022; 27 (1S): 4872. (In Russ.) https://doi.org/10.15829/1560-4071-2022-4872.

47. Sapelnikov O. V., Kulikov A. A., Cherkashin D. I., et al. Atrial fibrillation: development mechanisms, approaches and prospects of therapy. Racionalnaya farmakoterapiya v kardiologii. 2020; 16 (1): 118-125. (In Russ.) https://doi.org/10.20996/1819-6446-2020-02-15.

48. Vertkin A. L., Zairat'yants O. V., Zvyagintseva E. I., et al. Place of metabolic syndrome in the cardiovascular continuum. Lechaschi Vrach. 2008; 3: 71-74. (In Russ.)

49. Cuevas-Ramos D., Mehta R., Aguilar-Salinas C. A. Fibroblast Growth Factor 21 and Browning of White Adipose Tissue. Front. Physiol. 2019; 10: 37. https://doi.org/10.3389/fphys.2019.00037.